nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—ABCG2—epilepsy syndrome	0.136	0.422	CbGaD
Rabeprazole—CYP2C19—epilepsy syndrome	0.107	0.332	CbGaD
Rabeprazole—CYP2D6—epilepsy syndrome	0.0793	0.246	CbGaD
Rabeprazole—CYP1A1—Propofol—epilepsy syndrome	0.0186	0.0445	CbGbCtD
Rabeprazole—CYP1A1—Phenobarbital—epilepsy syndrome	0.0178	0.0425	CbGbCtD
Rabeprazole—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0172	0.041	CbGbCtD
Rabeprazole—CYP2C19—Felbamate—epilepsy syndrome	0.016	0.0381	CbGbCtD
Rabeprazole—CYP2C19—Trimethadione—epilepsy syndrome	0.016	0.0381	CbGbCtD
Rabeprazole—CYP2C19—Fosphenytoin—epilepsy syndrome	0.015	0.0359	CbGbCtD
Rabeprazole—CYP2C9—Trimethadione—epilepsy syndrome	0.0133	0.0317	CbGbCtD
Rabeprazole—CYP2C19—Clobazam—epilepsy syndrome	0.013	0.0311	CbGbCtD
Rabeprazole—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0125	0.0298	CbGbCtD
Rabeprazole—CYP2C19—Carbamazepine—epilepsy syndrome	0.0108	0.0258	CbGbCtD
Rabeprazole—CYP2C19—Primidone—epilepsy syndrome	0.0101	0.0241	CbGbCtD
Rabeprazole—CYP1A2—Carbamazepine—epilepsy syndrome	0.00995	0.0238	CbGbCtD
Rabeprazole—CYP2C19—Phenytoin—epilepsy syndrome	0.00967	0.0231	CbGbCtD
Rabeprazole—CYP1A2—Primidone—epilepsy syndrome	0.00929	0.0222	CbGbCtD
Rabeprazole—CYP2C19—Propofol—epilepsy syndrome	0.00902	0.0216	CbGbCtD
Rabeprazole—CYP2C9—Carbamazepine—epilepsy syndrome	0.00896	0.0214	CbGbCtD
Rabeprazole—CYP2C19—Phenobarbital—epilepsy syndrome	0.00862	0.0206	CbGbCtD
Rabeprazole—CYP2C9—Primidone—epilepsy syndrome	0.00837	0.02	CbGbCtD
Rabeprazole—CYP1A2—Propofol—epilepsy syndrome	0.00832	0.0199	CbGbCtD
Rabeprazole—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0083	0.0198	CbGbCtD
Rabeprazole—CYP2C19—Diazepam—epilepsy syndrome	0.00817	0.0195	CbGbCtD
Rabeprazole—CYP2C9—Phenytoin—epilepsy syndrome	0.00804	0.0192	CbGbCtD
Rabeprazole—CYP2C19—Zonisamide—epilepsy syndrome	0.00798	0.0191	CbGbCtD
Rabeprazole—CYP1A2—Phenobarbital—epilepsy syndrome	0.00795	0.019	CbGbCtD
Rabeprazole—CYP3A4—Felbamate—epilepsy syndrome	0.00772	0.0184	CbGbCtD
Rabeprazole—CYP3A4—Trimethadione—epilepsy syndrome	0.00772	0.0184	CbGbCtD
Rabeprazole—CYP1A2—Diazepam—epilepsy syndrome	0.00754	0.018	CbGbCtD
Rabeprazole—CYP2C9—Propofol—epilepsy syndrome	0.0075	0.0179	CbGbCtD
Rabeprazole—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00725	0.0173	CbGbCtD
Rabeprazole—CYP2C9—Phenobarbital—epilepsy syndrome	0.00717	0.0171	CbGbCtD
Rabeprazole—CYP2D6—Propofol—epilepsy syndrome	0.00686	0.0164	CbGbCtD
Rabeprazole—CYP2C9—Diazepam—epilepsy syndrome	0.00679	0.0162	CbGbCtD
Rabeprazole—CYP3A4—Clonazepam—epilepsy syndrome	0.00656	0.0157	CbGbCtD
Rabeprazole—CYP2C19—Valproic Acid—epilepsy syndrome	0.00644	0.0154	CbGbCtD
Rabeprazole—CYP3A4—Clobazam—epilepsy syndrome	0.00629	0.015	CbGbCtD
Rabeprazole—CYP1A2—Valproic Acid—epilepsy syndrome	0.00594	0.0142	CbGbCtD
Rabeprazole—CYP2C19—Topiramate—epilepsy syndrome	0.00581	0.0139	CbGbCtD
Rabeprazole—CYP2C9—Valproic Acid—epilepsy syndrome	0.00536	0.0128	CbGbCtD
Rabeprazole—CYP3A4—Rufinamide—epilepsy syndrome	0.00535	0.0128	CbGbCtD
Rabeprazole—CYP3A4—Carbamazepine—epilepsy syndrome	0.00521	0.0125	CbGbCtD
Rabeprazole—CYP3A4—Primidone—epilepsy syndrome	0.00487	0.0116	CbGbCtD
Rabeprazole—CYP3A4—Phenytoin—epilepsy syndrome	0.00467	0.0112	CbGbCtD
Rabeprazole—CYP3A4—Propofol—epilepsy syndrome	0.00436	0.0104	CbGbCtD
Rabeprazole—CYP3A4—Acetazolamide—epilepsy syndrome	0.00417	0.00996	CbGbCtD
Rabeprazole—CYP3A4—Phenobarbital—epilepsy syndrome	0.00417	0.00996	CbGbCtD
Rabeprazole—CYP3A4—Midazolam—epilepsy syndrome	0.00411	0.00982	CbGbCtD
Rabeprazole—CYP3A4—Diazepam—epilepsy syndrome	0.00395	0.00944	CbGbCtD
Rabeprazole—CYP3A4—Zonisamide—epilepsy syndrome	0.00386	0.00921	CbGbCtD
Rabeprazole—CYP3A4—Valproic Acid—epilepsy syndrome	0.00311	0.00744	CbGbCtD
Rabeprazole—CYP3A4—Topiramate—epilepsy syndrome	0.00281	0.00671	CbGbCtD
Rabeprazole—Omeprazole—CYP11A1—epilepsy syndrome	0.000583	0.18	CrCbGaD
Rabeprazole—Esomeprazole—CYP2C19—epilepsy syndrome	0.000378	0.117	CrCbGaD
Rabeprazole—Pantoprazole—ABCG2—epilepsy syndrome	0.000348	0.107	CrCbGaD
Rabeprazole—Omeprazole—ABCG2—epilepsy syndrome	0.000283	0.0875	CrCbGaD
Rabeprazole—Pantoprazole—CYP2C19—epilepsy syndrome	0.000273	0.0844	CrCbGaD
Rabeprazole—Lansoprazole—ABCG2—epilepsy syndrome	0.000259	0.0801	CrCbGaD
Rabeprazole—Omeprazole—CYP2C19—epilepsy syndrome	0.000223	0.0688	CrCbGaD
Rabeprazole—Lansoprazole—CYP2C19—epilepsy syndrome	0.000204	0.0629	CrCbGaD
Rabeprazole—Omeprazole—CYP2D6—epilepsy syndrome	0.000165	0.051	CrCbGaD
Rabeprazole—Lansoprazole—CYP2D6—epilepsy syndrome	0.000151	0.0467	CrCbGaD
Rabeprazole—Pantoprazole—ABCB1—epilepsy syndrome	0.000145	0.0447	CrCbGaD
Rabeprazole—Omeprazole—ABCB1—epilepsy syndrome	0.000118	0.0364	CrCbGaD
Rabeprazole—Lansoprazole—ABCB1—epilepsy syndrome	0.000108	0.0333	CrCbGaD
Rabeprazole—Dermatitis—Vigabatrin—epilepsy syndrome	2.43e-05	0.00012	CcSEcCtD
Rabeprazole—Urethral disorder—Topiramate—epilepsy syndrome	2.43e-05	0.00012	CcSEcCtD
Rabeprazole—Pruritus—Oxcarbazepine—epilepsy syndrome	2.43e-05	0.000119	CcSEcCtD
Rabeprazole—Convulsion—Pregabalin—epilepsy syndrome	2.43e-05	0.000119	CcSEcCtD
Rabeprazole—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.43e-05	0.000119	CcSEcCtD
Rabeprazole—Vision blurred—Gabapentin—epilepsy syndrome	2.42e-05	0.000119	CcSEcCtD
Rabeprazole—Headache—Vigabatrin—epilepsy syndrome	2.42e-05	0.000119	CcSEcCtD
Rabeprazole—Hypertension—Pregabalin—epilepsy syndrome	2.42e-05	0.000119	CcSEcCtD
Rabeprazole—Vomiting—Diazepam—epilepsy syndrome	2.42e-05	0.000119	CcSEcCtD
Rabeprazole—Anorexia—Valproic Acid—epilepsy syndrome	2.41e-05	0.000119	CcSEcCtD
Rabeprazole—Tremor—Gabapentin—epilepsy syndrome	2.41e-05	0.000118	CcSEcCtD
Rabeprazole—Rash—Diazepam—epilepsy syndrome	2.4e-05	0.000118	CcSEcCtD
Rabeprazole—Dermatitis—Diazepam—epilepsy syndrome	2.4e-05	0.000118	CcSEcCtD
Rabeprazole—Visual impairment—Topiramate—epilepsy syndrome	2.39e-05	0.000118	CcSEcCtD
Rabeprazole—Myalgia—Pregabalin—epilepsy syndrome	2.38e-05	0.000117	CcSEcCtD
Rabeprazole—Chest pain—Pregabalin—epilepsy syndrome	2.38e-05	0.000117	CcSEcCtD
Rabeprazole—Arthralgia—Pregabalin—epilepsy syndrome	2.38e-05	0.000117	CcSEcCtD
Rabeprazole—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.38e-05	0.000117	CcSEcCtD
Rabeprazole—Dizziness—Zonisamide—epilepsy syndrome	2.38e-05	0.000117	CcSEcCtD
Rabeprazole—Headache—Diazepam—epilepsy syndrome	2.38e-05	0.000117	CcSEcCtD
Rabeprazole—Anxiety—Pregabalin—epilepsy syndrome	2.38e-05	0.000117	CcSEcCtD
Rabeprazole—Diarrhoea—Clonazepam—epilepsy syndrome	2.38e-05	0.000117	CcSEcCtD
Rabeprazole—Anaemia—Gabapentin—epilepsy syndrome	2.37e-05	0.000117	CcSEcCtD
Rabeprazole—Hypotension—Valproic Acid—epilepsy syndrome	2.36e-05	0.000116	CcSEcCtD
Rabeprazole—Asthenia—Carbamazepine—epilepsy syndrome	2.36e-05	0.000116	CcSEcCtD
Rabeprazole—Agitation—Gabapentin—epilepsy syndrome	2.36e-05	0.000116	CcSEcCtD
Rabeprazole—Diarrhoea—Phenytoin—epilepsy syndrome	2.36e-05	0.000116	CcSEcCtD
Rabeprazole—Discomfort—Pregabalin—epilepsy syndrome	2.36e-05	0.000116	CcSEcCtD
Rabeprazole—Nausea—Fosphenytoin—epilepsy syndrome	2.35e-05	0.000116	CcSEcCtD
Rabeprazole—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.35e-05	0.000116	CcSEcCtD
Rabeprazole—Erythema multiforme—Topiramate—epilepsy syndrome	2.35e-05	0.000116	CcSEcCtD
Rabeprazole—Angioedema—Gabapentin—epilepsy syndrome	2.35e-05	0.000116	CcSEcCtD
Rabeprazole—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.34e-05	0.000115	CcSEcCtD
Rabeprazole—Vomiting—Felbamate—epilepsy syndrome	2.34e-05	0.000115	CcSEcCtD
Rabeprazole—Dry mouth—Pregabalin—epilepsy syndrome	2.33e-05	0.000115	CcSEcCtD
Rabeprazole—Pruritus—Carbamazepine—epilepsy syndrome	2.33e-05	0.000115	CcSEcCtD
Rabeprazole—Rash—Felbamate—epilepsy syndrome	2.32e-05	0.000114	CcSEcCtD
Rabeprazole—Eye disorder—Topiramate—epilepsy syndrome	2.32e-05	0.000114	CcSEcCtD
Rabeprazole—Dermatitis—Felbamate—epilepsy syndrome	2.32e-05	0.000114	CcSEcCtD
Rabeprazole—Malaise—Gabapentin—epilepsy syndrome	2.32e-05	0.000114	CcSEcCtD
Rabeprazole—Tinnitus—Topiramate—epilepsy syndrome	2.31e-05	0.000114	CcSEcCtD
Rabeprazole—Vertigo—Gabapentin—epilepsy syndrome	2.31e-05	0.000114	CcSEcCtD
Rabeprazole—Headache—Felbamate—epilepsy syndrome	2.31e-05	0.000114	CcSEcCtD
Rabeprazole—Confusional state—Pregabalin—epilepsy syndrome	2.31e-05	0.000113	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.3e-05	0.000113	CcSEcCtD
Rabeprazole—Syncope—Gabapentin—epilepsy syndrome	2.3e-05	0.000113	CcSEcCtD
Rabeprazole—Leukopenia—Gabapentin—epilepsy syndrome	2.3e-05	0.000113	CcSEcCtD
Rabeprazole—Dizziness—Clonazepam—epilepsy syndrome	2.3e-05	0.000113	CcSEcCtD
Rabeprazole—Nausea—Vigabatrin—epilepsy syndrome	2.29e-05	0.000113	CcSEcCtD
Rabeprazole—Vomiting—Zonisamide—epilepsy syndrome	2.29e-05	0.000113	CcSEcCtD
Rabeprazole—Insomnia—Valproic Acid—epilepsy syndrome	2.29e-05	0.000113	CcSEcCtD
Rabeprazole—Oedema—Pregabalin—epilepsy syndrome	2.29e-05	0.000113	CcSEcCtD
Rabeprazole—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.29e-05	0.000113	CcSEcCtD
Rabeprazole—Asthenia—Lamotrigine—epilepsy syndrome	2.28e-05	0.000112	CcSEcCtD
Rabeprazole—Dizziness—Phenytoin—epilepsy syndrome	2.28e-05	0.000112	CcSEcCtD
Rabeprazole—Rash—Zonisamide—epilepsy syndrome	2.27e-05	0.000112	CcSEcCtD
Rabeprazole—Paraesthesia—Valproic Acid—epilepsy syndrome	2.27e-05	0.000112	CcSEcCtD
Rabeprazole—Palpitations—Gabapentin—epilepsy syndrome	2.27e-05	0.000112	CcSEcCtD
Rabeprazole—Dermatitis—Zonisamide—epilepsy syndrome	2.27e-05	0.000112	CcSEcCtD
Rabeprazole—Dizziness—Oxcarbazepine—epilepsy syndrome	2.27e-05	0.000112	CcSEcCtD
Rabeprazole—Nausea—Diazepam—epilepsy syndrome	2.26e-05	0.000111	CcSEcCtD
Rabeprazole—Loss of consciousness—Gabapentin—epilepsy syndrome	2.26e-05	0.000111	CcSEcCtD
Rabeprazole—Headache—Zonisamide—epilepsy syndrome	2.26e-05	0.000111	CcSEcCtD
Rabeprazole—Dyspnoea—Valproic Acid—epilepsy syndrome	2.25e-05	0.000111	CcSEcCtD
Rabeprazole—Diarrhoea—Carbamazepine—epilepsy syndrome	2.25e-05	0.000111	CcSEcCtD
Rabeprazole—Angiopathy—Topiramate—epilepsy syndrome	2.25e-05	0.000111	CcSEcCtD
Rabeprazole—Pruritus—Lamotrigine—epilepsy syndrome	2.25e-05	0.000111	CcSEcCtD
Rabeprazole—Shock—Pregabalin—epilepsy syndrome	2.25e-05	0.000111	CcSEcCtD
Rabeprazole—Somnolence—Valproic Acid—epilepsy syndrome	2.25e-05	0.000111	CcSEcCtD
Rabeprazole—Cough—Gabapentin—epilepsy syndrome	2.24e-05	0.00011	CcSEcCtD
Rabeprazole—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.24e-05	0.00011	CcSEcCtD
Rabeprazole—Tachycardia—Pregabalin—epilepsy syndrome	2.23e-05	0.00011	CcSEcCtD
Rabeprazole—Chills—Topiramate—epilepsy syndrome	2.23e-05	0.00011	CcSEcCtD
Rabeprazole—Dyspepsia—Valproic Acid—epilepsy syndrome	2.23e-05	0.00011	CcSEcCtD
Rabeprazole—Convulsion—Gabapentin—epilepsy syndrome	2.23e-05	0.00011	CcSEcCtD
Rabeprazole—Hypertension—Gabapentin—epilepsy syndrome	2.22e-05	0.000109	CcSEcCtD
Rabeprazole—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.21e-05	0.000109	CcSEcCtD
Rabeprazole—Vomiting—Clonazepam—epilepsy syndrome	2.21e-05	0.000109	CcSEcCtD
Rabeprazole—Decreased appetite—Valproic Acid—epilepsy syndrome	2.2e-05	0.000108	CcSEcCtD
Rabeprazole—Alopecia—Topiramate—epilepsy syndrome	2.19e-05	0.000108	CcSEcCtD
Rabeprazole—Vomiting—Phenytoin—epilepsy syndrome	2.19e-05	0.000108	CcSEcCtD
Rabeprazole—Rash—Clonazepam—epilepsy syndrome	2.19e-05	0.000108	CcSEcCtD
Rabeprazole—Dermatitis—Clonazepam—epilepsy syndrome	2.19e-05	0.000108	CcSEcCtD
Rabeprazole—Myalgia—Gabapentin—epilepsy syndrome	2.19e-05	0.000108	CcSEcCtD
Rabeprazole—Arthralgia—Gabapentin—epilepsy syndrome	2.19e-05	0.000108	CcSEcCtD
Rabeprazole—Chest pain—Gabapentin—epilepsy syndrome	2.19e-05	0.000108	CcSEcCtD
Rabeprazole—Nausea—Felbamate—epilepsy syndrome	2.19e-05	0.000108	CcSEcCtD
Rabeprazole—Vomiting—Oxcarbazepine—epilepsy syndrome	2.18e-05	0.000107	CcSEcCtD
Rabeprazole—Anxiety—Gabapentin—epilepsy syndrome	2.18e-05	0.000107	CcSEcCtD
Rabeprazole—Anorexia—Pregabalin—epilepsy syndrome	2.18e-05	0.000107	CcSEcCtD
Rabeprazole—Dizziness—Carbamazepine—epilepsy syndrome	2.18e-05	0.000107	CcSEcCtD
Rabeprazole—Diarrhoea—Lamotrigine—epilepsy syndrome	2.18e-05	0.000107	CcSEcCtD
Rabeprazole—Headache—Clonazepam—epilepsy syndrome	2.18e-05	0.000107	CcSEcCtD
Rabeprazole—Rash—Phenytoin—epilepsy syndrome	2.17e-05	0.000107	CcSEcCtD
Rabeprazole—Dermatitis—Phenytoin—epilepsy syndrome	2.17e-05	0.000107	CcSEcCtD
Rabeprazole—Rash—Oxcarbazepine—epilepsy syndrome	2.16e-05	0.000106	CcSEcCtD
Rabeprazole—Constipation—Valproic Acid—epilepsy syndrome	2.16e-05	0.000106	CcSEcCtD
Rabeprazole—Pain—Valproic Acid—epilepsy syndrome	2.16e-05	0.000106	CcSEcCtD
Rabeprazole—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.16e-05	0.000106	CcSEcCtD
Rabeprazole—Headache—Phenytoin—epilepsy syndrome	2.16e-05	0.000106	CcSEcCtD
Rabeprazole—Erythema—Topiramate—epilepsy syndrome	2.16e-05	0.000106	CcSEcCtD
Rabeprazole—Malnutrition—Topiramate—epilepsy syndrome	2.16e-05	0.000106	CcSEcCtD
Rabeprazole—Discomfort—Gabapentin—epilepsy syndrome	2.16e-05	0.000106	CcSEcCtD
Rabeprazole—Headache—Oxcarbazepine—epilepsy syndrome	2.15e-05	0.000106	CcSEcCtD
Rabeprazole—Nausea—Zonisamide—epilepsy syndrome	2.14e-05	0.000105	CcSEcCtD
Rabeprazole—Dry mouth—Gabapentin—epilepsy syndrome	2.14e-05	0.000105	CcSEcCtD
Rabeprazole—Hypotension—Pregabalin—epilepsy syndrome	2.14e-05	0.000105	CcSEcCtD
Rabeprazole—Flatulence—Topiramate—epilepsy syndrome	2.13e-05	0.000105	CcSEcCtD
Rabeprazole—Tension—Topiramate—epilepsy syndrome	2.12e-05	0.000104	CcSEcCtD
Rabeprazole—Dysgeusia—Topiramate—epilepsy syndrome	2.12e-05	0.000104	CcSEcCtD
Rabeprazole—Confusional state—Gabapentin—epilepsy syndrome	2.11e-05	0.000104	CcSEcCtD
Rabeprazole—Dizziness—Lamotrigine—epilepsy syndrome	2.1e-05	0.000104	CcSEcCtD
Rabeprazole—Nervousness—Topiramate—epilepsy syndrome	2.1e-05	0.000103	CcSEcCtD
Rabeprazole—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.1e-05	0.000103	CcSEcCtD
Rabeprazole—Oedema—Gabapentin—epilepsy syndrome	2.1e-05	0.000103	CcSEcCtD
Rabeprazole—Vomiting—Carbamazepine—epilepsy syndrome	2.09e-05	0.000103	CcSEcCtD
Rabeprazole—Back pain—Topiramate—epilepsy syndrome	2.09e-05	0.000103	CcSEcCtD
Rabeprazole—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.08e-05	0.000103	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.08e-05	0.000103	CcSEcCtD
Rabeprazole—Muscle spasms—Topiramate—epilepsy syndrome	2.08e-05	0.000102	CcSEcCtD
Rabeprazole—Rash—Carbamazepine—epilepsy syndrome	2.08e-05	0.000102	CcSEcCtD
Rabeprazole—Dermatitis—Carbamazepine—epilepsy syndrome	2.07e-05	0.000102	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.07e-05	0.000102	CcSEcCtD
Rabeprazole—Insomnia—Pregabalin—epilepsy syndrome	2.07e-05	0.000102	CcSEcCtD
Rabeprazole—Nausea—Clonazepam—epilepsy syndrome	2.06e-05	0.000102	CcSEcCtD
Rabeprazole—Headache—Carbamazepine—epilepsy syndrome	2.06e-05	0.000102	CcSEcCtD
Rabeprazole—Shock—Gabapentin—epilepsy syndrome	2.06e-05	0.000102	CcSEcCtD
Rabeprazole—Paraesthesia—Pregabalin—epilepsy syndrome	2.05e-05	0.000101	CcSEcCtD
Rabeprazole—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.05e-05	0.000101	CcSEcCtD
Rabeprazole—Nausea—Phenytoin—epilepsy syndrome	2.05e-05	0.000101	CcSEcCtD
Rabeprazole—Tachycardia—Gabapentin—epilepsy syndrome	2.05e-05	0.000101	CcSEcCtD
Rabeprazole—Dyspnoea—Pregabalin—epilepsy syndrome	2.04e-05	0.0001	CcSEcCtD
Rabeprazole—Nausea—Oxcarbazepine—epilepsy syndrome	2.04e-05	0.0001	CcSEcCtD
Rabeprazole—Vision blurred—Topiramate—epilepsy syndrome	2.04e-05	0.0001	CcSEcCtD
Rabeprazole—Somnolence—Pregabalin—epilepsy syndrome	2.03e-05	0.0001	CcSEcCtD
Rabeprazole—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.03e-05	9.98e-05	CcSEcCtD
Rabeprazole—Tremor—Topiramate—epilepsy syndrome	2.02e-05	9.97e-05	CcSEcCtD
Rabeprazole—Vomiting—Lamotrigine—epilepsy syndrome	2.02e-05	9.96e-05	CcSEcCtD
Rabeprazole—Urticaria—Valproic Acid—epilepsy syndrome	2.01e-05	9.89e-05	CcSEcCtD
Rabeprazole—Rash—Lamotrigine—epilepsy syndrome	2.01e-05	9.88e-05	CcSEcCtD
Rabeprazole—Ill-defined disorder—Topiramate—epilepsy syndrome	2.01e-05	9.87e-05	CcSEcCtD
Rabeprazole—Dermatitis—Lamotrigine—epilepsy syndrome	2e-05	9.87e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Valproic Acid—epilepsy syndrome	2e-05	9.84e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Valproic Acid—epilepsy syndrome	2e-05	9.84e-05	CcSEcCtD
Rabeprazole—Anorexia—Gabapentin—epilepsy syndrome	2e-05	9.84e-05	CcSEcCtD
Rabeprazole—Anaemia—Topiramate—epilepsy syndrome	2e-05	9.83e-05	CcSEcCtD
Rabeprazole—Headache—Lamotrigine—epilepsy syndrome	1.99e-05	9.81e-05	CcSEcCtD
Rabeprazole—Decreased appetite—Pregabalin—epilepsy syndrome	1.99e-05	9.78e-05	CcSEcCtD
Rabeprazole—Agitation—Topiramate—epilepsy syndrome	1.99e-05	9.77e-05	CcSEcCtD
Rabeprazole—Hypotension—Gabapentin—epilepsy syndrome	1.96e-05	9.64e-05	CcSEcCtD
Rabeprazole—Nausea—Carbamazepine—epilepsy syndrome	1.96e-05	9.63e-05	CcSEcCtD
Rabeprazole—Pain—Pregabalin—epilepsy syndrome	1.95e-05	9.62e-05	CcSEcCtD
Rabeprazole—Constipation—Pregabalin—epilepsy syndrome	1.95e-05	9.62e-05	CcSEcCtD
Rabeprazole—Malaise—Topiramate—epilepsy syndrome	1.95e-05	9.59e-05	CcSEcCtD
Rabeprazole—Vertigo—Topiramate—epilepsy syndrome	1.94e-05	9.56e-05	CcSEcCtD
Rabeprazole—Syncope—Topiramate—epilepsy syndrome	1.94e-05	9.54e-05	CcSEcCtD
Rabeprazole—Leukopenia—Topiramate—epilepsy syndrome	1.93e-05	9.52e-05	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.91e-05	9.4e-05	CcSEcCtD
Rabeprazole—Palpitations—Topiramate—epilepsy syndrome	1.91e-05	9.4e-05	CcSEcCtD
Rabeprazole—Loss of consciousness—Topiramate—epilepsy syndrome	1.9e-05	9.35e-05	CcSEcCtD
Rabeprazole—Insomnia—Gabapentin—epilepsy syndrome	1.9e-05	9.33e-05	CcSEcCtD
Rabeprazole—Nausea—Lamotrigine—epilepsy syndrome	1.89e-05	9.3e-05	CcSEcCtD
Rabeprazole—Cough—Topiramate—epilepsy syndrome	1.89e-05	9.28e-05	CcSEcCtD
Rabeprazole—Feeling abnormal—Pregabalin—epilepsy syndrome	1.88e-05	9.27e-05	CcSEcCtD
Rabeprazole—Paraesthesia—Gabapentin—epilepsy syndrome	1.88e-05	9.27e-05	CcSEcCtD
Rabeprazole—Convulsion—Topiramate—epilepsy syndrome	1.87e-05	9.22e-05	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.87e-05	9.2e-05	CcSEcCtD
Rabeprazole—Dyspnoea—Gabapentin—epilepsy syndrome	1.87e-05	9.2e-05	CcSEcCtD
Rabeprazole—Hypertension—Topiramate—epilepsy syndrome	1.87e-05	9.18e-05	CcSEcCtD
Rabeprazole—Somnolence—Gabapentin—epilepsy syndrome	1.86e-05	9.17e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.86e-05	9.17e-05	CcSEcCtD
Rabeprazole—Dyspepsia—Gabapentin—epilepsy syndrome	1.85e-05	9.08e-05	CcSEcCtD
Rabeprazole—Chest pain—Topiramate—epilepsy syndrome	1.84e-05	9.06e-05	CcSEcCtD
Rabeprazole—Myalgia—Topiramate—epilepsy syndrome	1.84e-05	9.06e-05	CcSEcCtD
Rabeprazole—Arthralgia—Topiramate—epilepsy syndrome	1.84e-05	9.06e-05	CcSEcCtD
Rabeprazole—Anxiety—Topiramate—epilepsy syndrome	1.83e-05	9.02e-05	CcSEcCtD
Rabeprazole—Decreased appetite—Gabapentin—epilepsy syndrome	1.82e-05	8.97e-05	CcSEcCtD
Rabeprazole—Discomfort—Topiramate—epilepsy syndrome	1.82e-05	8.95e-05	CcSEcCtD
Rabeprazole—Urticaria—Pregabalin—epilepsy syndrome	1.82e-05	8.94e-05	CcSEcCtD
Rabeprazole—Asthenia—Valproic Acid—epilepsy syndrome	1.81e-05	8.93e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Pregabalin—epilepsy syndrome	1.81e-05	8.9e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Pregabalin—epilepsy syndrome	1.81e-05	8.9e-05	CcSEcCtD
Rabeprazole—Dry mouth—Topiramate—epilepsy syndrome	1.8e-05	8.86e-05	CcSEcCtD
Rabeprazole—Pain—Gabapentin—epilepsy syndrome	1.79e-05	8.82e-05	CcSEcCtD
Rabeprazole—Constipation—Gabapentin—epilepsy syndrome	1.79e-05	8.82e-05	CcSEcCtD
Rabeprazole—Pruritus—Valproic Acid—epilepsy syndrome	1.79e-05	8.81e-05	CcSEcCtD
Rabeprazole—Confusional state—Topiramate—epilepsy syndrome	1.78e-05	8.75e-05	CcSEcCtD
Rabeprazole—Oedema—Topiramate—epilepsy syndrome	1.76e-05	8.68e-05	CcSEcCtD
Rabeprazole—Shock—Topiramate—epilepsy syndrome	1.74e-05	8.54e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Valproic Acid—epilepsy syndrome	1.73e-05	8.52e-05	CcSEcCtD
Rabeprazole—Feeling abnormal—Gabapentin—epilepsy syndrome	1.73e-05	8.5e-05	CcSEcCtD
Rabeprazole—Thrombocytopenia—Topiramate—epilepsy syndrome	1.73e-05	8.5e-05	CcSEcCtD
Rabeprazole—Tachycardia—Topiramate—epilepsy syndrome	1.72e-05	8.47e-05	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.71e-05	8.44e-05	CcSEcCtD
Rabeprazole—Hyperhidrosis—Topiramate—epilepsy syndrome	1.7e-05	8.39e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Pregabalin—epilepsy syndrome	1.68e-05	8.29e-05	CcSEcCtD
Rabeprazole—Anorexia—Topiramate—epilepsy syndrome	1.68e-05	8.27e-05	CcSEcCtD
Rabeprazole—Dizziness—Valproic Acid—epilepsy syndrome	1.67e-05	8.23e-05	CcSEcCtD
Rabeprazole—Urticaria—Gabapentin—epilepsy syndrome	1.67e-05	8.2e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Gabapentin—epilepsy syndrome	1.66e-05	8.16e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Gabapentin—epilepsy syndrome	1.66e-05	8.16e-05	CcSEcCtD
Rabeprazole—Hypotension—Topiramate—epilepsy syndrome	1.65e-05	8.11e-05	CcSEcCtD
Rabeprazole—Asthenia—Pregabalin—epilepsy syndrome	1.64e-05	8.07e-05	CcSEcCtD
Rabeprazole—Pruritus—Pregabalin—epilepsy syndrome	1.62e-05	7.96e-05	CcSEcCtD
Rabeprazole—Vomiting—Valproic Acid—epilepsy syndrome	1.61e-05	7.91e-05	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.61e-05	7.91e-05	CcSEcCtD
Rabeprazole—Insomnia—Topiramate—epilepsy syndrome	1.6e-05	7.85e-05	CcSEcCtD
Rabeprazole—Rash—Valproic Acid—epilepsy syndrome	1.59e-05	7.85e-05	CcSEcCtD
Rabeprazole—Dermatitis—Valproic Acid—epilepsy syndrome	1.59e-05	7.84e-05	CcSEcCtD
Rabeprazole—Headache—Valproic Acid—epilepsy syndrome	1.58e-05	7.8e-05	CcSEcCtD
Rabeprazole—Paraesthesia—Topiramate—epilepsy syndrome	1.58e-05	7.8e-05	CcSEcCtD
Rabeprazole—Dyspnoea—Topiramate—epilepsy syndrome	1.57e-05	7.74e-05	CcSEcCtD
Rabeprazole—Somnolence—Topiramate—epilepsy syndrome	1.57e-05	7.72e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Pregabalin—epilepsy syndrome	1.56e-05	7.7e-05	CcSEcCtD
Rabeprazole—Dyspepsia—Topiramate—epilepsy syndrome	1.55e-05	7.64e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Gabapentin—epilepsy syndrome	1.54e-05	7.6e-05	CcSEcCtD
Rabeprazole—Decreased appetite—Topiramate—epilepsy syndrome	1.53e-05	7.55e-05	CcSEcCtD
Rabeprazole—Dizziness—Pregabalin—epilepsy syndrome	1.51e-05	7.44e-05	CcSEcCtD
Rabeprazole—Constipation—Topiramate—epilepsy syndrome	1.51e-05	7.42e-05	CcSEcCtD
Rabeprazole—Pain—Topiramate—epilepsy syndrome	1.51e-05	7.42e-05	CcSEcCtD
Rabeprazole—Asthenia—Gabapentin—epilepsy syndrome	1.5e-05	7.4e-05	CcSEcCtD
Rabeprazole—Nausea—Valproic Acid—epilepsy syndrome	1.5e-05	7.39e-05	CcSEcCtD
Rabeprazole—Pruritus—Gabapentin—epilepsy syndrome	1.48e-05	7.3e-05	CcSEcCtD
Rabeprazole—Vomiting—Pregabalin—epilepsy syndrome	1.45e-05	7.15e-05	CcSEcCtD
Rabeprazole—Feeling abnormal—Topiramate—epilepsy syndrome	1.45e-05	7.15e-05	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.44e-05	7.1e-05	CcSEcCtD
Rabeprazole—Rash—Pregabalin—epilepsy syndrome	1.44e-05	7.1e-05	CcSEcCtD
Rabeprazole—Dermatitis—Pregabalin—epilepsy syndrome	1.44e-05	7.09e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Gabapentin—epilepsy syndrome	1.43e-05	7.06e-05	CcSEcCtD
Rabeprazole—Headache—Pregabalin—epilepsy syndrome	1.43e-05	7.05e-05	CcSEcCtD
Rabeprazole—Urticaria—Topiramate—epilepsy syndrome	1.4e-05	6.9e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Topiramate—epilepsy syndrome	1.39e-05	6.86e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Topiramate—epilepsy syndrome	1.39e-05	6.86e-05	CcSEcCtD
Rabeprazole—Dizziness—Gabapentin—epilepsy syndrome	1.39e-05	6.82e-05	CcSEcCtD
Rabeprazole—Nausea—Pregabalin—epilepsy syndrome	1.36e-05	6.68e-05	CcSEcCtD
Rabeprazole—Vomiting—Gabapentin—epilepsy syndrome	1.33e-05	6.56e-05	CcSEcCtD
Rabeprazole—Rash—Gabapentin—epilepsy syndrome	1.32e-05	6.51e-05	CcSEcCtD
Rabeprazole—Dermatitis—Gabapentin—epilepsy syndrome	1.32e-05	6.5e-05	CcSEcCtD
Rabeprazole—Headache—Gabapentin—epilepsy syndrome	1.31e-05	6.46e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Topiramate—epilepsy syndrome	1.3e-05	6.4e-05	CcSEcCtD
Rabeprazole—Asthenia—Topiramate—epilepsy syndrome	1.27e-05	6.23e-05	CcSEcCtD
Rabeprazole—Pruritus—Topiramate—epilepsy syndrome	1.25e-05	6.14e-05	CcSEcCtD
Rabeprazole—Nausea—Gabapentin—epilepsy syndrome	1.25e-05	6.13e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Topiramate—epilepsy syndrome	1.21e-05	5.94e-05	CcSEcCtD
Rabeprazole—Dizziness—Topiramate—epilepsy syndrome	1.17e-05	5.74e-05	CcSEcCtD
Rabeprazole—Vomiting—Topiramate—epilepsy syndrome	1.12e-05	5.52e-05	CcSEcCtD
Rabeprazole—Rash—Topiramate—epilepsy syndrome	1.11e-05	5.47e-05	CcSEcCtD
Rabeprazole—Dermatitis—Topiramate—epilepsy syndrome	1.11e-05	5.47e-05	CcSEcCtD
Rabeprazole—Headache—Topiramate—epilepsy syndrome	1.1e-05	5.44e-05	CcSEcCtD
Rabeprazole—Nausea—Topiramate—epilepsy syndrome	1.05e-05	5.16e-05	CcSEcCtD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.06e-06	0.000152	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	8.05e-06	0.000152	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AQP1—epilepsy syndrome	7.87e-06	0.000149	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	7.82e-06	0.000148	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	7.75e-06	0.000146	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GAMT—epilepsy syndrome	7.72e-06	0.000146	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	7.72e-06	0.000146	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PNPO—epilepsy syndrome	7.72e-06	0.000146	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	7.72e-06	0.000146	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	7.69e-06	0.000145	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	7.69e-06	0.000145	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	7.61e-06	0.000144	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NEU1—epilepsy syndrome	7.58e-06	0.000143	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ATIC—epilepsy syndrome	7.58e-06	0.000143	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—UPB1—epilepsy syndrome	7.58e-06	0.000143	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.56e-06	0.000143	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	7.54e-06	0.000142	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	7.52e-06	0.000142	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP2D6—epilepsy syndrome	7.49e-06	0.000141	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NT5E—epilepsy syndrome	7.41e-06	0.00014	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALAD—epilepsy syndrome	7.41e-06	0.00014	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ADSL—epilepsy syndrome	7.37e-06	0.000139	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NT5E—epilepsy syndrome	7.35e-06	0.000139	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALAD—epilepsy syndrome	7.35e-06	0.000139	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	7.29e-06	0.000138	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GLUL—epilepsy syndrome	7.23e-06	0.000136	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CA4—epilepsy syndrome	7.17e-06	0.000135	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—QDPR—epilepsy syndrome	7.17e-06	0.000135	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	7.15e-06	0.000135	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.15e-06	0.000135	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	7.13e-06	0.000135	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—KCNJ11—epilepsy syndrome	7.12e-06	0.000134	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CHRM3—epilepsy syndrome	7.12e-06	0.000134	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—BCHE—epilepsy syndrome	7.1e-06	0.000134	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	7.09e-06	0.000134	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	7.07e-06	0.000133	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	7.07e-06	0.000133	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	7.04e-06	0.000133	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GBE1—epilepsy syndrome	7.04e-06	0.000133	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	7.01e-06	0.000132	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	7.01e-06	0.000132	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	6.92e-06	0.000131	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.89e-06	0.00013	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	6.86e-06	0.000129	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ADSL—epilepsy syndrome	6.78e-06	0.000128	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	6.78e-06	0.000128	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.74e-06	0.000127	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ADSL—epilepsy syndrome	6.72e-06	0.000127	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PLCB1—epilepsy syndrome	6.7e-06	0.000127	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—TH—epilepsy syndrome	6.68e-06	0.000126	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GLUL—epilepsy syndrome	6.65e-06	0.000125	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	6.64e-06	0.000125	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.63e-06	0.000125	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	6.62e-06	0.000125	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GLUL—epilepsy syndrome	6.59e-06	0.000124	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	6.53e-06	0.000123	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.5e-06	0.000123	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	6.47e-06	0.000122	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	6.44e-06	0.000122	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AQP1—epilepsy syndrome	6.44e-06	0.000122	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.39e-06	0.000121	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.39e-06	0.000121	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.39e-06	0.000121	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.39e-06	0.000121	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.39e-06	0.000121	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NT5E—epilepsy syndrome	6.28e-06	0.000119	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALAD—epilepsy syndrome	6.28e-06	0.000119	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.19e-06	0.000117	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	6.1e-06	0.000115	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	6.05e-06	0.000114	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	5.99e-06	0.000113	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	5.99e-06	0.000113	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AQP1—epilepsy syndrome	5.93e-06	0.000112	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AQP1—epilepsy syndrome	5.87e-06	0.000111	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	5.86e-06	0.000111	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.85e-06	0.00011	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.85e-06	0.00011	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.85e-06	0.00011	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	5.83e-06	0.00011	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	5.83e-06	0.00011	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	5.8e-06	0.00011	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ADSL—epilepsy syndrome	5.74e-06	0.000108	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	5.66e-06	0.000107	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.64e-06	0.000106	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GLUL—epilepsy syndrome	5.63e-06	0.000106	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.63e-06	0.000106	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	5.62e-06	0.000106	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.58e-06	0.000105	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—HMOX1—epilepsy syndrome	5.57e-06	0.000105	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	5.53e-06	0.000104	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CAT—epilepsy syndrome	5.5e-06	0.000104	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.44e-06	0.000103	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.44e-06	0.000103	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.43e-06	0.000102	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	5.36e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	5.36e-06	0.000101	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ABCB1—epilepsy syndrome	5.35e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.32e-06	0.0001	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	5.31e-06	0.0001	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	5.31e-06	0.0001	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	5.17e-06	9.76e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.11e-06	9.65e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.09e-06	9.6e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	5.07e-06	9.58e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AQP1—epilepsy syndrome	5.02e-06	9.48e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GPX1—epilepsy syndrome	4.97e-06	9.39e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.97e-06	9.39e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.95e-06	9.34e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.85e-06	9.15e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.85e-06	9.15e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.85e-06	9.15e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	4.83e-06	9.12e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.82e-06	9.1e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—BCHE—epilepsy syndrome	4.81e-06	9.08e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	4.75e-06	8.97e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.62e-06	8.73e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.62e-06	8.73e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	4.6e-06	8.68e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	4.59e-06	8.66e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.57e-06	8.62e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	4.54e-06	8.57e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	4.54e-06	8.57e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	4.54e-06	8.57e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.52e-06	8.54e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—TH—epilepsy syndrome	4.52e-06	8.54e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.45e-06	8.4e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.43e-06	8.37e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.37e-06	8.25e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AGT—epilepsy syndrome	4.36e-06	8.23e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.35e-06	8.2e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	4.33e-06	8.17e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—APOE—epilepsy syndrome	4.27e-06	8.07e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.27e-06	8.05e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.26e-06	8.04e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	4.23e-06	7.99e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.23e-06	7.98e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	4.22e-06	7.97e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	4.19e-06	7.92e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.16e-06	7.86e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.16e-06	7.86e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	4.15e-06	7.84e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.14e-06	7.82e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.99e-06	7.53e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	3.95e-06	7.46e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.94e-06	7.43e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.87e-06	7.31e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.8e-06	7.17e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.79e-06	7.15e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	3.77e-06	7.12e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.75e-06	7.09e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CAT—epilepsy syndrome	3.72e-06	7.03e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.71e-06	7.01e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	3.7e-06	6.99e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—TH—epilepsy syndrome	3.7e-06	6.98e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—POMC—epilepsy syndrome	3.67e-06	6.93e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.64e-06	6.88e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.63e-06	6.86e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	3.62e-06	6.84e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.62e-06	6.83e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	3.61e-06	6.81e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.6e-06	6.8e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.59e-06	6.77e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	3.58e-06	6.77e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.56e-06	6.72e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.5e-06	6.61e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.5e-06	6.61e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.45e-06	6.52e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.42e-06	6.46e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.42e-06	6.45e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—TH—epilepsy syndrome	3.4e-06	6.42e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.39e-06	6.39e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—TH—epilepsy syndrome	3.37e-06	6.37e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GPX1—epilepsy syndrome	3.37e-06	6.36e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ALB—epilepsy syndrome	3.35e-06	6.32e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.32e-06	6.27e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.24e-06	6.12e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	3.23e-06	6.11e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	3.09e-06	5.83e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	3.08e-06	5.81e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—BCHE—epilepsy syndrome	3.07e-06	5.79e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CAT—epilepsy syndrome	3.05e-06	5.75e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.96e-06	5.6e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AGT—epilepsy syndrome	2.95e-06	5.57e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTGS2—epilepsy syndrome	2.93e-06	5.53e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.93e-06	5.52e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.89e-06	5.46e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—APOE—epilepsy syndrome	2.89e-06	5.46e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—TH—epilepsy syndrome	2.88e-06	5.44e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.86e-06	5.39e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.84e-06	5.36e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.84e-06	5.36e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.82e-06	5.32e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.8e-06	5.29e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.78e-06	5.25e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.78e-06	5.24e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.77e-06	5.22e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.76e-06	5.2e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.73e-06	5.15e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.7e-06	5.1e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.53e-06	4.78e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.51e-06	4.74e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.5e-06	4.71e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—POMC—epilepsy syndrome	2.49e-06	4.69e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.42e-06	4.56e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	2.41e-06	4.54e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.38e-06	4.49e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CAT—epilepsy syndrome	2.37e-06	4.48e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.37e-06	4.47e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.37e-06	4.47e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	2.31e-06	4.36e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALB—epilepsy syndrome	2.27e-06	4.28e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.26e-06	4.26e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.23e-06	4.22e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—TH—epilepsy syndrome	2.22e-06	4.2e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.22e-06	4.2e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.2e-06	4.16e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.18e-06	4.11e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.16e-06	4.07e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.15e-06	4.05e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—POMC—epilepsy syndrome	2.03e-06	3.84e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	1.98e-06	3.74e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.88e-06	3.55e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.87e-06	3.53e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.86e-06	3.51e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.85e-06	3.5e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.85e-06	3.5e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.84e-06	3.48e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.83e-06	3.46e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.78e-06	3.36e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.71e-06	3.22e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.69e-06	3.19e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.66e-06	3.13e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.62e-06	3.06e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.58e-06	2.99e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.49e-06	2.82e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.48e-06	2.79e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AKT1—epilepsy syndrome	1.47e-06	2.78e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.45e-06	2.74e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.44e-06	2.73e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.42e-06	2.69e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.26e-06	2.39e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.22e-06	2.31e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.11e-06	2.1e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AKT1—epilepsy syndrome	9.96e-07	1.88e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.75e-07	1.84e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AKT1—epilepsy syndrome	8.15e-07	1.54e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AKT1—epilepsy syndrome	7.5e-07	1.42e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AKT1—epilepsy syndrome	7.43e-07	1.4e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKT1—epilepsy syndrome	6.35e-07	1.2e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.9e-07	9.25e-06	CbGpPWpGaD
